China Life Insurance Co., Ltd.
12F China Life Plaza A No.16 Financial Street, Xicheng District Beijing China 100033
Tel: 86-10-63633333
Fax: 86-10-66575722
E-mail: ir@e-chinalife.com
China Life Insurance Company Limited
China Life Insurance Company Limited
19-12-2003
1
This announcement is for information purposes only and does not constitute an invitation or offer to acquire, purchase or
subscribe for securities.
The Stock Exchange of Hong Kong Limited takes no responsibility for the contents of this announcement, makes no
representation as to its accuracy or completeness and expressly disclaims any liability whatsoever for any loss howsoever
arising from or in reliance upon the whole or any part of the contents of this announcement.
Unless otherwise defined in this announcement, terms defined in the prospectus of the Company dated December 8, 2003 (the
“Prospectus”) have the same meanings when used in this announcement.
CHINA LIFE INSURANCE COMPANY LIMITED
(A joint stock limited company incorporated in the People’s Republic of China with limited liability)
EXERCISE OF OVER-ALLOTMENT OPTION
The Company announces that the Over-allotment Option mentioned in the Prospectus was
exercised in full by the Joint Global Coordinators on behalf of the International Underwriters and
the US Underwriters on December 18, 2003 in respect of an aggregate of 970,587,000 H Shares
(which are deliverable in the form of ADSs), representing approximately 15% of the Offer Shares
initially available under the Global Offering.
882,352,000 H Shares will be issued and allotted by the Company, and 88,235,000 H Shares will
be sold by the Selling Shareholder, at HK$3.625 per H Share, being the same price per H Share
under the International Offering and the US Offering. This price is equivalent to the Offer Price
in the Hong Kong Public Offering of HK$3.59 (plus 1% brokerage, 0.005% SFC transaction levy,
0.002% investor compensation levy and 0.005% Stock Exchange trading fee).
The Company announces that the Over-allotment Option mentioned in the Prospectus was exercised
in full by the Joint Global Coordinators on behalf of the International Underwriters and the US
Underwriters on December 18, 2003 in respect of an aggregate of 970,587,000 H Shares (the “Over-
allotment Shares”, which are deliverable in the form of ADSs), representing approximately 15% of
the Offer Shares initially available under the Global Offering. Among the Over-allotment Shares,
882,352,000 H Shares will be issued and allotted by the Company, and 88,235,000 H Shares will be
sold by the Selling Shareholder, both at HK$3.625 per H Share, being the same price per H Share
under the International Offering and the US Offering. This price is equivalent to the Offer Price in
the Hong Kong Public Offering of HK$3.59 (plus 1% brokerage, 0.005% SFC transaction levy,
0.002% investor compensation levy and 0.005% Stock Exchange trading fee). Listing of and
permission to deal in the Over-allotment Shares have already been granted by the Listing Committee
of the Stock Exchange. Dealings in such Over-allotment Shares are expected to commence on the
Main Board of the Stock Exchange at 9:30 a.m. on December 22, 2003.China Life Insurance Company Limited
China Life Insurance Company Limited
19-12-2003
2
The shareholding structure of the Company immediately before and immediately after the issue by
the Company and the sale by the Selling Shareholder of the Over-allotment Shares are as follows:
Immediately before the issue and Immediately after the issue and
sale of the Over-allotment Shares sale of the Over-allotment Shares
Number of Approximate Number of Approximate
Domestic Shares/ percentage of Domestic Shares/ percentage of
Shareholder H Shares issued share capital H Shares issued share capital
Selling Shareholder 19,411,765,000 75.00% 19,323,530,000 72.20%
Domestic Shares Domestic Shares
Public shareholders 6,470,588,000 25.00% 7,441,175,000 27.80%
H Shares H Shares
Total number of Shares 25,882,353,000 100.00% 26,764,705,000 100.00%
Shares Shares
The net proceeds of approximately HK$3,086 million from the issue of 882,352,000 H Shares by the
Company will be used by the Company to increase its level of paid-in capital and further strengthen
its solvency level, and the net proceeds of approximately HK$308.6 million from the sale of
88,235,000 H Shares by the Selling Shareholder will be remitted to the Chinese National Social
Security Fund in accordance with PRC regulations.
By Order of the Board
Wang Xianzhang
Chairman of the Board
Hong Kong, December 18, 2003
Please also refer to the published version of this announcement in South China Morning Post dated
on 19-12-2003.